| Product Code: ETC7222135 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Legalized Cannabis Medical Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Legalized Cannabis Medical Market Revenues & Volume, 2021 & 2031F |
3.3 France Legalized Cannabis Medical Market - Industry Life Cycle |
3.4 France Legalized Cannabis Medical Market - Porter's Five Forces |
3.5 France Legalized Cannabis Medical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 France Legalized Cannabis Medical Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 France Legalized Cannabis Medical Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 France Legalized Cannabis Medical Market Revenues & Volume Share, By Compound, 2021 & 2031F |
4 France Legalized Cannabis Medical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of medical cannabis for various health conditions |
4.2.2 Growing demand for alternative and natural treatment options |
4.2.3 Favorable government regulations and policies supporting the medical cannabis market |
4.3 Market Restraints |
4.3.1 Limited availability of medical cannabis products and dispensaries |
4.3.2 Stringent regulations and compliance requirements |
4.3.3 Stigma and societal perceptions surrounding cannabis use in healthcare |
5 France Legalized Cannabis Medical Market Trends |
6 France Legalized Cannabis Medical Market, By Types |
6.1 France Legalized Cannabis Medical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 France Legalized Cannabis Medical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 France Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Herb, 2021- 2031F |
6.1.4 France Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Resin, 2021- 2031F |
6.2 France Legalized Cannabis Medical Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 France Legalized Cannabis Medical Market Revenues & Volume, By Raw, 2021- 2031F |
6.2.3 France Legalized Cannabis Medical Market Revenues & Volume, By Processed, 2021- 2031F |
6.3 France Legalized Cannabis Medical Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 France Legalized Cannabis Medical Market Revenues & Volume, By Recreational, 2021- 2031F |
6.3.3 France Legalized Cannabis Medical Market Revenues & Volume, By Medicinal, 2021- 2031F |
6.4 France Legalized Cannabis Medical Market, By Compound |
6.4.1 Overview and Analysis |
6.4.2 France Legalized Cannabis Medical Market Revenues & Volume, By THC-Dominant, 2021- 2031F |
6.4.3 France Legalized Cannabis Medical Market Revenues & Volume, By CBD-Dominant, 2021- 2031F |
6.4.4 France Legalized Cannabis Medical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
7 France Legalized Cannabis Medical Market Import-Export Trade Statistics |
7.1 France Legalized Cannabis Medical Market Export to Major Countries |
7.2 France Legalized Cannabis Medical Market Imports from Major Countries |
8 France Legalized Cannabis Medical Market Key Performance Indicators |
8.1 Number of medical professionals prescribing cannabis-based treatments |
8.2 Patient satisfaction and reported health improvements with medical cannabis usage |
8.3 Research and development investments in cannabis-based pharmaceuticals |
8.4 Number of clinical trials and studies on the efficacy of medical cannabis |
8.5 Government funding and support for cannabis research and development |
9 France Legalized Cannabis Medical Market - Opportunity Assessment |
9.1 France Legalized Cannabis Medical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 France Legalized Cannabis Medical Market Opportunity Assessment, By Form, 2021 & 2031F |
9.3 France Legalized Cannabis Medical Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 France Legalized Cannabis Medical Market Opportunity Assessment, By Compound, 2021 & 2031F |
10 France Legalized Cannabis Medical Market - Competitive Landscape |
10.1 France Legalized Cannabis Medical Market Revenue Share, By Companies, 2024 |
10.2 France Legalized Cannabis Medical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here